Covid-19, non-Covid-19 and excess mortality rates not comparable across countries

被引:20
|
作者
Kelly, Gabrielle [1 ]
Petti, Stefano [2 ]
Noah, Norman [3 ]
机构
[1] Univ Coll Dublin, Sch Math & Stat, Dublin, Ireland
[2] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy
[3] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England
来源
EPIDEMIOLOGY AND INFECTION | 2021年 / 149卷
关键词
Covid-19; mortality and excess mortality rates per country; variables associated with Covid-19 and excess mortality rates;
D O I
10.1017/S0950268821001850
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Evidence that more people in some countries and fewer in others are dying because of the pandemic, than is reflected by reported coronavirus disease 2019 (Covid-19) mortality rates, is derived from mortality data. Using publicly available databases, deaths attributed to Covid-19 in 2020 and all deaths for the years 2015-2020 were tabulated for 35 countries together with economic, health, demographic and government response stringency index variables. Residual mortality rates (RMR) in 2020 were calculated as excess mortality minus reported mortality rates due to Covid-19 where excess deaths were observed deaths in 2020 minus the average for 2015-2019. Differences in RMR are differences not attributed to reported Covid-19. For about half the countries, RMR's were negative and for half, positive. The absolute rates in some countries were double those in others. In a regression analysis, population density and proportion of female smokers were positively associated with both Covid-19 and excess mortality while the human development index and proportion of male smokers were negatively associated with both. RMR was not associated with any of the investigated variables. The results show that published data on mortality from Covid-19 cannot be directly comparable across countries. This may be due to differences in Covid-19 death reporting and in addition, the unprecedented public health measures implemented to control the pandemic may have produced either increased or reduced excess deaths due to other diseases. Further data on cause-specific mortality is required to determine the extent to which residual mortality represents non-Covid-19 deaths and to explain differences between countries.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] The COVID-19 Pandemic and the Incidence of the Non-COVID-19 Pneumonia in Adults
    Huang, Chienhsiu
    FRONTIERS IN MEDICINE, 2021, 8
  • [32] Thrombosis in Covid-19 and non-Covid-19 pneumonia: role of platelets
    Violi, Francesco
    Cammisotto, Vittoria
    Pignatelli, Pasquale
    PLATELETS, 2021, 32 (08) : 1009 - 1017
  • [33] Has the COVID-19 pandemic changed non-COVID-19 healthcare utilisation patterns across Europe?
    Aldridge, S. J.
    Schmidt, A. E.
    Owens, R.
    Dolanski-Aghamanoukjan, L.
    Mathis-Edenhofer, S.
    Lyons, R. A.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2023, 33
  • [34] High severity and mortality of non-COVID-19 critically ill patients during the COVID-19 pandemic
    Kim, S.
    Sim, J. K.
    Jung, W. J.
    Lee, Y. S.
    Kim, J. H.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [35] Comparison of COVID-19 and Non-COVID-19 Tracheostomised Patients: Complications, Survival, and Mortality Risk Factors
    Mesalles-Ruiz, Marta
    Alonso, Maitane
    Cruellas, Marc
    Plana, Marti
    Penella, Anna
    Portillo, Alejandro
    Gumucio, Victor Daniel
    Gonzalez-Compta, Xavier
    Manos, Manel
    Nogues, Julio
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [36] Characteristics of candidemia in COVID-19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non-COVID-19 patients
    Kayaaslan, Bircan
    Eser, Fatma
    Bilgic, Zeynep
    Asilturk, Dilek
    Hasanoglu, Imran
    Ayhan, Muge
    Tekce, Yasemin Tezer
    Erdem, Deniz
    Turan, Sema
    Mumcuoglu, Ipek
    Guner, Rahmet
    MYCOSES, 2021, 64 (09) : 1083 - 1091
  • [37] Education and COVID-19 excess mortality
    Bello, Piera
    Rocco, Lorenzo
    ECONOMICS & HUMAN BIOLOGY, 2022, 47
  • [38] CISATRACURIUM DOSING REQUIREMENTS IN COVID-19 COMPARED TO NON-COVID-19 PATIENTS
    Ingebrigtson, Megan
    Farina, Nicholas
    Miller, James
    Renius, Karl
    Kenes, Michael
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 128 - 128
  • [39] Cisatracurium Dosing Requirements in COVID-19 Compared to Non-COVID-19 Patients
    Ingebrigtson, Megan
    Farina, Nicholas
    Miller, James
    Renius, Karl
    McSparron, Jakob I.
    Kenes, Michael
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (03) : 485 - 486
  • [40] The impact of the COVID-19 disease on the referral and admission of the non-COVID-19 patients
    Zakeri, Mohammad Ali
    Dehghan, Mahlagha
    INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT, 2021, 36 (01): : 209 - 211